Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Published:2020-11-03 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Li Long,Zhu Xiqun,Qian Yu,Yuan Xiangling,Ding Yi,Hu Desheng,He Xin,Wu Yuan

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference100 articles.

1. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial;Stupp;JAMA,2017

2. Epidemiologic and molecular prognostic review of glioblastoma;Thakkar;Cancer Epidemiol Biomarkers Prev,2014

3. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

4. High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Stupp;Ann Oncol,2014

5. Glioblastoma Multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment;Hanif;Asian Pac J Cancer Prev,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

2. Neuroinflammation in Glioblastoma: Progress and Perspectives;Brain Sciences;2024-07-09

3. A scientometric analysis of immunotherapies for gliomas: Focus on GBM;Asian Journal of Surgery;2024-03

4. Effective extracellular vesicles in glioma: Focusing on effective ncRNA exosomes and immunotherapy methods for treatment;Cell Biochemistry and Function;2024-01

5. Recent advances in targeted drug delivery for the treatment of glioblastoma;Nanoscale;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3